Ping An Securities research report suggests laying out the three main lines of 'recovery,' 'going global,' and 'innovation' in the healthcare and biopharmaceutical industry. 1) The 'recovery' theme focuses on quality companies in tracks with warming economic conditions, with attention to Zhejiang Starry Pharmaceutical and KPC Pharmaceuticals, Inc. 2) The 'going global' theme is the huge opportunities of the overseas market, with attention to Shenzhen New Industries Biomedical Engineering and Kexing Biopharm, among others. 3) The 'innovation' theme is to lay out investment opportunities in sub-fields such as Alzheimer's disease, nuclear medicine, autoimmunity, and high-end transdermal patches, focusing on Changzhou Qianhong Biopharma, Joinn Laboratories, and others.
平安证券：围绕医药生物行业三条主线进行布局
Ping An Securities: Set up layouts around the three main lines of the CSI SWS Health Care Index.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.